Tech Company Financing Transactions

Kurome Therapeutics Funding Round

On 6/11/2021, Kurome Therapeutics raised $15 million in Series A funding from Affinity Asset Advisors, Medicxi Ventures and CincyTech.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3536 Edwards Rd. 100
Cincinnati, OH 45208
USA

Phone

(513) 445-3852

Website

www.kurometherapeutics.com

Email Address

[email protected]

Overview

Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

John Rice

        

Chief Executive Officer

Jan Rosenbaum

        

Browse more venture capital transactions:

Prev: 6/11/2021: Loupe Tech venture capital transaction
Next: 6/11/2021: TestBox venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary